World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
64116
World Ranking
19913
National Ranking
9916

Overview

John H. Bond was affiliated with the Veterans Health Administration in the United States. Their research focused primarily on medicine with additional involvement in biochemistry, genetics, and molecular biology.

The scientist's work covered several subfields including pulmonary and respiratory medicine, oncology, genetics, molecular biology, and cancer research. The main topics in their research explored advanced breast cancer therapies, chronic lymphocytic leukemia research, PI3K/AKT/mTOR signaling in cancer, cancer treatment and pharmacology, breast cancer treatment studies, estrogen and related hormone effects, and colorectal cancer screening and detection.

John H. Bond published research in various venues, with repeated contributions to these outlets:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • UNC Libraries

Frequent co-authors included Komal Jhaveri, Valentina Boni, Aditya Bardia, Peter Schmid, and Elgene Lim, each collaborating on multiple occasions.

Some of the recent publications attributed to John H. Bond were:

  • Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers, 2020, Clinical Cancer Research
  • Safety and activity of single-agent giredestrant (GDC-9545) from a phase Ia/b study in patients (pts) with estrogen receptor-positive (ER+), HER2-negative locally advanced/metastatic breast cancer (LA/mBC), 2021, Journal of Clinical Oncology
  • Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) operable breast cancer (BC), 2021, Journal of Clinical Oncology
  • Colorectal Cancer in Patients Under Close Colonoscopic Surveillance, 2021, UNC Libraries

Best Publications

  • Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

    S J Winawer;A G Zauber;M N Ho;M J O'Brien

  • Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

    Sidney J. Winawer;Ann G. Zauber;Robert H. Fletcher;Jonathon S. Stillman

  • Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

    Bernard Levin;David A Lieberman;Beth McFarland;Kimberly S Andrews

  • Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood

    Mandel Js;Bond Jh;Church Tr;Snover Dc

  • Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

    Ann G. Zauber;Sidney J. Winawer;Michael J. O'Brien;Iris Lansdorp-Vogelaar

  • COLORECTAL CANCER SCREENING AND SURVEILLANCE: CLINICAL GUIDELINES AND RATIONALE-UPDATE BASED ON NEW EVIDENCE

    Sidney Winawer;Robert Fletcher;Douglas Rex;John Bond

  • Colorectal cancer screening: Clinical guidelines and rationale

    SJ Winawer;RH Fletcher;L Miller;F Godlee

  • Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer

    David A. Lieberman;David G. Weiss;John H. Bond;Dennis J. Ahnen

  • The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

    Jack S. Mandel;Timothy R. Church;John H. Bond;Fred Ederer

  • A randomized trial of aspirin to prevent colorectal adenomas

    John A. Baron;Bernard F. Cole;Robert S. Sandler;Robert W. Haile

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: Recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer

    Douglas K. Rex;John H. Bond;Sidney Winawer;Theodore R. Levin

  • Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps

    Winawer Sj;Zauber Ag;O'Brien Mj;Ho Mn

  • Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

    Bernard F. Cole;John A. Baron;Robert S. Sandler;Robert W. Haile

  • Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood

    Jack S. Mandel;Timothy R. Church;Fred Ederer;John H. Bond

  • Calcium Supplements for the Prevention of Colorectal Adenomas

    Baron Ja;Beach M;Beach M;Mandel Js;van Stolk Ru

  • Long-term mortality after screening for colorectal cancer.

    Aasma Shaukat;Steven J. Mongin;Mindy S. Geisser;Frank A. Lederle

  • A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma

    E. Robert Greenberg;John A. Baron;Tor D. Tosteson;Daniel H. Freeman

  • Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients

    E McColl;A Jacoby;L Thomas;J Soutter

  • A Comparison of Colonoscopy and Double-Contrast Barium Enema for Surveillance after Polypectomy

    Winawer Sj;Stewart Et;Zauber Ag;Bond Jh

Frequent Co-Authors

Sidney J. Winawer
Sidney J. Winawer Memorial Sloan Kettering Cancer Center
Michael Levitt
Michael Levitt Stanford University
Michael J. O'Brien
Michael J. O'Brien Tulane University
Timothy R. Church
Timothy R. Church University of Minnesota
Ann G. Zauber
Ann G. Zauber Memorial Sloan Kettering Cancer Center
Bernard Levin
Bernard Levin The University of Texas MD Anderson Cancer Center
John A. Baron
John A. Baron University of North Carolina at Chapel Hill
Dennis J. Ahnen
Dennis J. Ahnen University of Colorado Denver
Ian G. McKeith
Ian G. McKeith Newcastle University
Martin P Eccles
Martin P Eccles Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers alongside or as an alternative to traditional medical school, there are several accessible online pathways to consider. Many students look to flexible options that fit their schedules, such as rn to bsn online no clinicals accredited programs, which allow registered nurses to earn a Bachelor of Science in Nursing degree completely online and without required clinical hours.

For nurses seeking advanced practice roles, short dnp programs can accelerate your path to a Doctor of Nursing Practice. Some may also wish to explore the easiest dnp programs, designed with flexible coursework and fewer barriers for experienced professionals.

Individuals eager to enter the nursing field quickly might benefit from lpn program options online. These fast-track programs can help you start your healthcare career in less time with the required licensure. Exploring these online degrees provides multiple paths into medicine and healthcare, meeting a wide range of career ambitions and educational backgrounds.

Best Scientists Citing John H. Bond